GCM
MDT icon

Graham Capital Management’s Medtronic MDT Stock Holding History

Graham Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,082
Closed -$2.61M – 1401
2026
Q1 		$2.61M Sell
30,082
-8,560
-22% -$820K 0.06% 222
2025
Q4 		$3.71M Sell
38,642
-8,600
-18% -$835K 0.09% 147
2025
Q3 		$4.5M Buy
+47,242
New +$4.34M 0.07% 122
2025
Q1 		– Sell
-16,548
Closed -$1.32M – 1422
2024
Q4 		$1.32M Buy
+16,548
New +$1.43M 0.02% 418
2024
Q1 		– Sell
-83,279
Closed -$6.86M – 1209
2023
Q4 		$6.86M Sell
83,279
-55,272
-40% -$4.21M 0.15% 95
2023
Q3 		$10.9M Buy
+138,551
New +$11.6M 0.26% 68
2017
Q3 		– Sell
-13,600
Closed -$1.21M – 76
2017
Q2 		$1.21M Buy
+13,600
New +$1.15M 0.03% 45
2015
Q1 		– Sell
-40,000
Closed -$2.89M – 142
2014
Q4 		$2.89M Buy
+40,000
New +$2.78M 0.12% 98

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Graham Capital Management's MDT Position: Q2 2026 in Review

Graham Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 30,082 shares — an estimated $2.61M sold.

Graham Capital Management first reported a position in MDT in Q4 2014 and held it in 8 quarters. The position peaked at $10.9M in Q3 2023. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Graham Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 30,082 Medtronic shares in Q2 2026, an estimated $2.61M.
  • Graham Capital Management first reported a position in Medtronic in Q4 2014 and held it in 8 quarters.
  • Graham Capital Management's Medtronic position peaked at $10.9M in Q3 2023.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.